Pelthos Therapeutics Inc (PTHS) Q4 2025 Earnings Call Highlights: Prescription Surge and ... [Yahoo! Finance]
Pelthos Therapeutics Inc. (PTHS)
Company Research
Source: Yahoo! Finance
Prescription Growth: 129% increase in prescriptions from 2,716 units in Q3 to 6,232 units in Q4. Cost of Goods Sold: $1.7 million in Q4 2025. SG&A Expenses: $18.5 million in Q4 2025, with $13.5 million as steady-state cash expenses. Net Operating Loss: Improved from $15.4 million in Q3 to $12.0 million in Q4 2025. Adjusted EBITDA Loss: Improved from $11.5 million in Q3 to $9.0 million in Q4 2025. Cash Balance: $18.0 million as of December 31, 2025. Convertible Note and Term Debt: Closed an $18 million convertible note in November and a $15 million term debt loan in January, drawing $30 million. Gross-to-Net (GTN) Rate: 28.7% for Q4 2025, expected to move to mid- to upper-30% range. Sales Team Expansion: Increased from 50 to 64 territory managers. Warning! GuruFocus has detected 4 Warning Signs with PTHS. Is PTHS fairly valued? Test your thesis with our free DCF calculator. Release Date: March 19, 2026 For the complete transcript of the earnings call, please re
Show less
Read more
Impact Snapshot
Event Time:
PTHS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTHS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTHS alerts
High impacting Pelthos Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
PTHS
News
- Pelthos Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Pelthos Therapeutics to Present at 38th Annual ROTH Conference [Yahoo! Finance]Yahoo! Finance
- Pelthos Therapeutics to Present at 38th Annual ROTH ConferenceGlobeNewswire
PTHS
Earnings
- 3/19/26 - Miss
PTHS
Sec Filings
- 3/19/26 - Form 8-K
- 3/19/26 - Form 10-K
- 2/17/26 - Form SCHEDULE
- PTHS's page on the SEC website